Form 4: Alto Neuroscience CFO Increases Stake in Company with Recent Stock Purchases
SEC Form 4 Filing
Nicholas Conrad Smith, CFO of Alto Neuroscience, recently acquired additional shares of the company's common stock through open market purchases.
Summary
- Nicholas Conrad Smith, the Chief Financial Officer of Alto Neuroscience, Inc. (ANRO), reported changes in beneficial ownership of the company's stock.
- On March 28, 2024, Smith purchased 1,600 shares of common stock at $15.80 per share and 4,550 shares at $16.56 per share.
- Following these transactions, Smith directly owns 26,866 shares of Alto Neuroscience, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed as a positive signal, but the filing itself is simply a procedural disclosure.
Positives
- The CFO's purchase of company stock could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track confidence levels and potential alignment of interests.
Stakeholder Impact
- Shareholders may view the CFO's stock purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of stock purchase transactions |
| 04/01/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.